Biological, Diagnostic and Therapeutic Advances in Alzheimer's Disease

This book discusses the latest research into the highly prevalent neurodevelopmental disease most commonly associated with aging: Alzheimer’s disease (AD). Even after years of research, Alzheimer’s disease is still far from being cured. It presents a range of common symptoms in the form of behavioral and cognitive impairments. This book describes the symptoms and the biology behind them. 

The contents covers latest findings on the genetics involved and various factors and pathways influencing disease development. It also covers various non-pharmacological therapies like immunotherapy, use of natural products, and employing nanotechnology in both the detection and treatment of AD. This book also highlights the role of diet and nutrition in healthy aging. Given its scope, it offers a valuable asset for researchers and clinicians alike. 

• alzheimer's
• Biological Mechanism
• Biomarkers
• Immunotherapy
• Nanotechnological applications
• Diagnosis
• rehabilitation psychology

• King Fahd Medical Research Center, King Abdulaziz University Jeddah, Saudi Arabia, Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia

  Ghulam Md Ashraf

• Novel Global Community Educational Foundation, Hebersham, NSW, Australia, AFNP Med, Wien, Austria

  Athanasios Alexiou

Dr Ghulam Md Ashraf, currently working as an Associate Professor at King Fahd Medical Research Centre, King Abdulaziz University, Saudi Arabia, completed his PhD in Biochemistry at Aligarh Muslim University, Uttar Pradesh, India. His main research interests are in Proteomics and Neurology. He is also a Research Consultant/Supervisor at Glocal University, India, and an Honorary Faculty Member at the Novel Global Community Educational Foundation (NGCEF), Australia. He has acted as a Principal Investigator or Co-Investigator in various research projects funded by reputed funding agencies, e.g. the Deanship of Scientific Research (DSR), King Abdulaziz University, Saudi Arabia and Strategic Technologies Research Program, King Abdulaziz City for Science and Technology (KACST), Saudi Arabia. He is a Member of the Editorial Board of various journals, e.g. Scientific Reports (Nature Publishing Group), Journal of Proteomics (Elsevier), Frontiers in Aging Neuroscience, etc. He is also affiliated with the Protein Society, USA, the Science Advisory Board, and Saudi Society for Genomics and Molecular Oncology, Saudi Arabia. He has published 178 articles in various national and international journals. 

Dr. Athanasios Alexiou is a Mathematician with a Ph.D. in Bioinformatics Algorithms and Mathematical Modeling in Biology and a two-year Postdoctoral Research Fellowship in Neuroinformatics Applications. He currently serves as an Honorary Vice President and Faculty Member at the Novel Global Community Education Foundation (NGCEF), Australia and as Head of the Scientific Advisory Board of the AFNP Med Company in Austria. His main research field is Biomedical Informatics, with a special interest in Medical Decision Support Systems, Algorithms in Neuroinformatics and Computational Biomedicine, Neurodegenerative Diseases and Biomarker Modeling. He is an Associate Editor of the journals Genetics, Pharmacology and Sociology, a Guest Associate Editor of the Frontiers Neuroscience Journal for the Research Topic 'The Alzheimer's Disease Challenge', and the author/co-author of several peer-reviewed scientific papers in various journals and books. 

Policies and ethics